LMP2-DC Vaccine Elicits Specific EBV-LMP2 Response to Effectively Improve Immunotherapy in Patients with Nasopharyngeal Cancer.

Yi Zeng(Duke University), Hui Lin(The People's Hospital of Guangxi Zhuang Autonomous Region), Jiao Lan(Hunan University), Gui Ping Lan(The People's Hospital of Guangxi Zhuang Autonomous Region), Juan Tang(Air Force Medical University), Oh Sj(Nova Southeastern University), Yong Feng(Wuhan University), Ling Zhou, Yong Wang(Nanjing Institute of Geology and Paleontology), Zhan Wang(National Institute for Viral Disease Control and Prevention), Xiang Zhou(The People's Hospital of Guangxi Zhuang Autonomous Region), Min Zhong Tang(Wuzhou Red Cross Hospital), Zhi Xiang Zhou(Beijing University of Technology), Hai Jun Du(National Institute for Viral Disease Control and Prevention)
PubMed
November 20, 2020
Cited by 17


Related Papers